ClinicalTrials.gg
Not yet recruitingNCT07575074Updated May 8, 2026

OKT With Gaze and Postural Stabilization on Vertigo, MS and QOL in VBH

An interventional study of Group A Habituation exercises and Group B Optokinetic training protocol in Vestibular Disorder, sponsored by Riphah International University. Not yet recruiting at 1 site in Pakistan. Open to participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-05-08.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
All
01

Study summary

The objective of this study will evaluate the effects of optokinetic training combined with postural stabilization and gaze stability exercises on motion sickness, balance, gaze stability, and quality of life in individuals with vestibular hypofunction.

Read the detailed description

A randomized clinical trial will be conducted with 32 participants assigned to two groups: Group A (breathing and aerobic exercises) and Group B (optokinetic training combined with postural stabilization and gaze stability exercises). Data will be collected using the Motion Sickness Susceptibility Questionnaire (MSSQ), Berg Balance Scale (BBS), Dynamic Visual Acuity Test for Gaze Stability, and Head Impulse Test. Statistical analysis will be performed by SPSS.

02

Conditions studied

  • Vestibular Disorder

Keywords

  • Balance
  • gaze stability
  • motion sickness
  • optokinetic training
03

In context

Vestibular Diseases

170 studies on the registry are indexed under Vestibular Diseases; 41 are open to participants now.

This study's planned enrollment of 32 is below the median of 46 across 127 interventional studies indexed under Vestibular Diseases.

Browse Vestibular Diseases studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Male and female patients age 20 and 40 years

      • Passengers who have motion sickness during travelling
      • Patients of vestibular migraine who experience motion sickness
      • Participants experiencing vertigo, dizziness or imbalance related to vestibular hypofunction over the past three months

Exclusion criteria

Exclusion Criteria:

    • Patients who have seasickness and simulator sickness excluded.

      • Patients having vestibular disease and chronic neurological disease.
      • Participants who have completed formal vestibular rehabilitation in last 6 months excluded
      • Patients with severe visual impairments and orthopedic conditions excluded.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
32 participants (estimated)

Study arms

  • Experimental
    Group A Habituation exercises

    Group A performed a regime of Habituation exercises five times per week to improve overall wellness and reduce baseline symptoms of motion sickness

    Other: Group A Habituation exercises

  • Experimental
    Group B Optokinetic training protocol

    Group B underwent a structured optokinetic training protocol combined with postural stabilization and gaze stability exercises, targeting both gaze and postural control systems.

    Other: Group B Optokinetic training protocol

Interventions

  • OtherGroup A Habituation exercises

    Habituation exercises five times per week to improve overall wellness and reduce baseline symptoms of motion sickness (38). Each session, lasting approximately 20-25 minutes, involved exercises conducted for 20 minutes per day, five times a week. Each session, lasting approximately 30-45 minutes, included low-intensity breathing exercises aimed at promoting relaxation and moderate-intensity aerobic activities, such as walking or cycling, at 50-60% of the participant's maximum heart rate.

  • OtherGroup B Optokinetic training protocol

    10-minute warm-up, followed by 20-25 minutes of moderate-intensity optokinetic exercises (viewing controlled moving visual patterns), postural exercises involving controlled head and body movements to engage the vestibular system, and gaze stability exercises, which require focusing on a stationary target during head movements to improve the vestibulo-ocular reflex. The session concluded with a 10-15-minute cool-down to aid relaxation. These sessions continued for 12 weeks

06

What researchers measure

Primary outcomes

  1. Motion sickness susceptibility questionnaire

    The Motion Sickness Susceptibility Questionnaire (MSSQ) is a widely used tool that assesses an individual's predisposition to motion sickness in various environments, such as vehicles, amusement rides, and virtual reality.

    Time frame: 8th week

  2. Berg balance scale

    The Berg Balance Scale (BBS) is a reliable clinical tool used to assess balance in individuals, particularly older adults and those with balance impairments. It includes 14 tasks each scored from 0 (cannot perform) to 4 (performs independently). The BBS has a maximum score of 56, and most of the patients show a low fall risk of 41 to 56 scores, medium risk of 21 to 40 scores, and a high risk of 0 to 20 scores.

    Time frame: 8th week

  3. Dynamic visual acuity test for gaze stability

    The Dynamic Visual Acuity (DVA) Test is a widely used clinical test to assess gaze stability, particularly in individuals with vestibular dysfunction. It evaluates a person's ability to maintain clear vision during head movements, which requires stable gaze control. The test involves reading porotype letters or symbols displayed on a screen, first in a stationary position and then while moving the head horizontally and vertically at a standardized speed (usually around 2 Hz)

    Time frame: 8th week

  4. Head impulse test

    The Head Impulse Test (HIT) is a diagnostic tool used to evaluate the function of the vestibulo-ocular reflex (VOR), essential for maintaining gaze stability during rapid head movements. In this test, a clinician rapidly and unpredictably turns the patient's head to the left or right while the patient focuses on a stationary target, typically the clinician's nose. For a healthy VOR, the eyes should remain fixed on the target despite the head movement

    Time frame: 8th week

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07575074
Responsible party
Sponsor
First posted
May 8, 2026
Start date
May 15, 2026 (estimated)
Primary completion
Aug 15, 2026 (estimated)
Completion
Sep 14, 2026 (estimated)
Last update
May 8, 2026

Study contacts

Muneeb Khan, PhD
Contact
muneeb.khan@riphah.edu.pk
923367993611
Javeria Ghazal, MSNMPT
principal investigator · Riphah International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion